PRPF31 antibody (C-Term)
Quick Overview for PRPF31 antibody (C-Term) (ABIN5538006)
Target
See all PRPF31 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 334-361, C-Term
-
Purification
- This antibody is purified through a protein A column, followed by peptide affinity purification.
-
Immunogen
- This PRPF31 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 334-361 amino acids from the C-terminal region of human PRPF31.
-
Isotype
- Ig Fraction
-
-
-
-
Application Notes
- For WB starting dilution is: 1:1000
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.5 mg/mL
-
Buffer
- Supplied in PBS with 0.09 % (W/V) sodium azide.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- 4 °C,-20 °C
-
Storage Comment
- Store at 4°C for three months and -20°C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.
-
-
- PRPF31 (Pre-mRNA Processing Factor 31 (PRPF31))
-
Alternative Name
- PRPF31
-
Background
- This gene encodes a component of the spliceosome complex and is one of several retinitis pigmentosa-causing genes. When the gene product is added to the spliceosome complex, activation occurs.
-
Molecular Weight
- 55 kDa
-
Gene ID
- 26121
-
UniProt
- Q8WWY3
-
Pathways
- Ribonucleoprotein Complex Subunit Organization
Target
-